T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on ...
A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...
Scientists at École Polytechnique Fédérale Lausanne (EPFL), and at UNIL-CHUV, University Hospital Lausanne (CHUV) and University of Lausanne (UNIL) have developed a computational method to create ...
A collaborative effort among researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and ...
Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before. This breakthrough may help explain why immunotherapy works for some ...
New research links atopic dermatitis to S1P signalling pathways driving inflammation. Learn how this could shape future ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of refractory or relapsed leukemia and hematologic malignancies, particularly over the past decade. Despite its ...
A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered immunotherapy for solid tumors, according to a new study by Stanford Medicine ...